BIOVIE INC.·5

Oct 21, 6:11 PM ET

MARKHAM PENELOPE 5

5 · BIOVIE INC. · Filed Oct 21, 2020

Insider Transaction Report

Form 5
Period: 2020-06-30
MARKHAM PENELOPE
EVP Liver Cirrhosis R&D
Transactions
  • Award

    options

    [F1]
    2020-01-19$2.80/sh+800$2,2403,200 total
    Exercise: $2.80From: 2020-01-19Exp: 2025-01-19common stock (800 underlying)
Footnotes (1)
  • [F1]On 11/21/2019 a reverse stock split was effected; derivative securities are post-split calculations.
Signature
Steven F. Lincoln, attorney in fact for Penelope Markham|2020-10-21

Documents

1 file
  • 5
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT